An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies

K Iffland, F Grotenhermen - Cannabis and cannabinoid research, 2017 - liebertpub.com
Introduction: This literature survey aims to extend the comprehensive survey performed by
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …

The essential medicinal chemistry of cannabidiol (CBD)

KM Nelson, J Bisson, G Singh, JG Graham… - Journal of medicinal …, 2020 - ACS Publications
This Perspective of the published essential medicinal chemistry of cannabidiol (CBD)
provides evidence that the popularization of CBD-fortified or CBD-labeled health products …

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors

T Bakas, PS Van Nieuwenhuijzen, SO Devenish… - Pharmacological …, 2017 - Elsevier
Cannabidiol (CBD) is a major non-intoxicating component of cannabis and possesses anti-
epileptic, anxiolytic and anti-hyperalgesic properties. The mechanism of action of CBD in …

Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome

LL Anderson, IK Low, SD Banister… - Journal of natural …, 2019 - ACS Publications
Cannabis sativa produces a complex mixture of many bioactive molecules including
terpenophenolic compounds known as phytocannabinoids. Phytocannabinoids come in …

Cannabinoids, blood–brain barrier, and brain disposition

F Calapai, L Cardia, EE Sorbara, M Navarra… - Pharmaceutics, 2020 - mdpi.com
Potential therapeutic actions of the cannabinoids delta-9-tetrahydrocannabinol (THC) and
cannabidiol (CBD) are based on their activity as analgesics, anti-emetics, anti-inflammatory …

Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations

LL Anderson, MG Etchart, D Bahceci… - Scientific reports, 2021 - nature.com
Cannabis is a complex mixture of hundreds of bioactive molecules. This provides the
potential for pharmacological interactions between cannabis constituents, a phenomenon …

Cannabidiol for the treatment of brain disorders: therapeutic potential and routes of administration

GTY Yau, W Tai, JC Arnold, HK Chan… - Pharmaceutical …, 2023 - Springer
The use of cannabidiol (CBD) for treating brain disorders has gained increasing interest.
While the mechanism of action of CBD in these conditions is still under investigation, CBD …

Modeling blood–brain barrier pathology in cerebrovascular disease in vitro: current and future paradigms

AV Andjelkovic, SM Stamatovic, CM Phillips… - Fluids and Barriers of …, 2020 - Springer
The complexity of the blood–brain barrier (BBB) and neurovascular unit (NVU) was and still
is a challenge to bridge. A highly selective, restrictive and dynamic barrier, formed at the …

Oral delivery of cannabidiol: revealing the formulation and absorption challenges

A Sitovs, K Logviss, L Lauberte, V Mohylyuk - Journal of Drug Delivery …, 2024 - Elsevier
Cannabidiol (CBD) is a pharmacologically active, non-psychoactive cannabinoid derived
from natural sources. Currently, it is available in prescription oral dosage forms for its anti …

A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics

EJ Cox, N Maharao, G Patilea-Vrana… - Pharmacology & …, 2019 - Elsevier
Abstract In the United States, the evolving landscape of state-legal marijuana use for
recreational and/or medical purposes has given rise to flourishing markets for marijuana and …